MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma
Clinical trial NCT04834024 · RECRUITING
Trial details
- NCT number
- NCT04834024
- Sponsor
- Beijing Mabworks Biotech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-02
- Primary completion
- 2025-03-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.